Slippery slopes, wonder drugs, and cosmetic neurology
The neuroethics of enhancement
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Drug therapies that are already available can help patients improve their muscle mass and endurance, attention and memory, ability to learn, and moods. Future research, Anjan Chatterjee argues in this issue of Neurology, will almost certainly produce relatively safe wonder drugs that will allow us to manipulate our strength, our memory, our ability to concentrate, and our capacity to learn.1 Once these drugs are available, he contends, the pressures of the marketplace and of potential military uses will compel us to embrace them to remain competitive. To some extent, this discussion has an air of unreality: for the foreseeable future, any drug powerful enough to enhance brain functions significantly is likely to have serious side effects, especially with prolonged use. But if we accept the premise that safe neurologic enhancement technologies will eventually become available, then we face two important moral questions: 1) What kind of doctors should neurologists be? 2) What kind of society should we become? The answer to the first obviously depends on the second. So the question of whether neurologists should become, as Chatterjee suggests, “lifestyle consultants” who dispense fixes for the mind the way plastic surgeons offer fixes for the body does not even arise unless the mere availability of these treatments implies that neurologists must prescribe them to whoever seeks them. Putting the …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Fabricio Ferreira de Oliveira and Dr. Alan Cronemberger Andrade
► Watch
Related Articles
Alert Me
Recommended articles
-
Historical Neurology
Neurology's witness to history: Part IILeo Alexander's contributions to the Nuremberg Code (1946 to 1947)Michael I. Shevell et al.Neurology, January 01, 1998 -
Views & Reviews
Cosmetic neurologyThe controversy over enhancing movement, mentation, and moodAnjan Chatterjee et al.Neurology, September 27, 2004 -
In This Issue
September 28 Highlightset al.Neurology, September 27, 2004 -
Views & Reviews
Pediatric neuroenhancementEthical, legal, social, and neurodevelopmental implicationsWilliam D. Graf, Saskia K. Nagel, Leon G. Epstein et al.Neurology, March 13, 2013